The Treatment of Cutaneous T-cell Lymphoma with Triple Combination of Interferon alfa, Retinoid, and Photochemotherapy.
10.5021/ad.2004.16.1.39
- Author:
Jeong Deuk LEE
;
Ji Sun LEE
;
Sang Hyun CHO
;
Chi Hwa HAN
- Publication Type:Case Report
- Keywords:
Cutaneous T cell lymphoma;
Interferon alfa;
PUVA;
Retinoid
- MeSH:
Adult;
Drug Therapy;
Ficusin;
Humans;
Interferon-alpha*;
Interferons*;
Lymphoma;
Lymphoma, T-Cell, Cutaneous*;
Photochemotherapy*;
Quality of Life;
T-Lymphocytes
- From:Annals of Dermatology
2004;16(1):39-41
- CountryRepublic of Korea
- Language:English
-
Abstract:
Cutaneous T-cell lymphoma(CTCL) is a rare cutaneous malignant disease and is typically a disease of older adults. There is no optimal treatment for CTCL, which ranges from topical steroid to systemic chemotherapy. Hence until curative therapy is found, therapies that keep CTCL in check and prevent progression to more advanced lymphoma may be desirable alternatives and may presetve quality of life. Herein we report our experience in treating a stage 11B CTCL patient with triple combination of interferon alfa, oral retinoid, and psoralen plus WA(PWA) therapy.
